Notably, dasatinib inhibits STAT‐5 signalling associated with apoptosis in K562 CML cells,48 and it inhibits Src and STAT‐5 phosphorylation along with apoptosis induction in acute lymphoblastic leukaemia cells.49 The gene discussed is SRC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.